AzTrials
AzTrials

Healthy IndividualsNCT07340385

Physiological and Biochemical Responses to Blood Flow Restriction Training

An observational study of Healthy Individuals and Trained Athletes, run by Afyonkarahisar Health Sciences University at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study is designed to examine the short-term and long-term effects of blood flow restriction exercise training on physiological and biochemical markers in individuals who are new to strength training and in experienced athletes training at different load levels. Read more about this study

Who is it for?
Ages 18 to 40 years, men onlyHealthy volunteers can take part
Conditions the study is for
Healthy Individuals, Trained Athletes
What is being tested?
Blood Flow Restriction Training
How many people
30 participants
Where
1 siteTurkey (Türkiye)
Study dates
20 Jan 2026to 20 Mar 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Study population: The study population consists of healthy adults aged 18-40 years, including individuals who are new to strength training and experienced athletes from different sports disciplines with varying training load levels.

Who may be able to join

  • Voluntary participation of healthy adults
  • Age between 18 and 40 years
  • No history of orthopedic pathology or current symptoms affecting the lower extremities
  • For individuals with prior training experience: engagement in strength training at least two days per week for the past year across different sports disciplines
  • For individuals new to strength training: no regular participation in strength training within the past six months

Who cannot join

  • History of hypertension, cardiovascular diseases, peripheral vascular diseases, deep vein thrombosis, neurological disorders, obesity, or a diagnosis of diabetes
  • Current or previous diagnosis of cancer
  • Individuals who do not consent to participate in the study

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Turkey (Türkiye)1 site, 1 recruiting
  • Afyonkarahisar Health Sciences University

    Afyonkarahisar, Merkez, 03030

    Fatma EKEN, 05365241207, fatmaeken08@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: The Effects of Training History on Physiological and Biochemical Responses in Blood Flow Restriction Strength Training

This study is designed to examine the short-term and long-term effects of blood flow restriction exercise training on physiological and biochemical markers in individuals who are new to strength training and in experienced athletes training at different load levels. This exercise method involves placing a special inflatable cuff around the upper part of the thigh. The cuff partially limits blood flow to the area, which helps the muscles work more effectively during exercise. The cuff will be applied only to the individual's dominant leg (the leg you use more often in daily activities), but all exercises will be performed using both legs. The exercise program will last for a total of six weeks and will be carried out twice per week. The pressure applied by the cuff will be individually adjusted based on each participant's physical characteristics to ensure safety and comfort. The study will include a total of 30 healthy participants aged between 18 and 40 years. Participants will be divided into two groups: individuals who have recently started strength training and experienced athletes with different levels of training experience.

Being tested
Blood Flow Restriction Training
Keywords
Strength Training, Oxidative Stress, Growth Factors, Biochemical Markers, Muscle Thickness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Blood Flow Restriction TrainingOther

    Adaptation to blood flow restriction exercise training and the individually tailored occlusion pressure will be determined during the initial sessions. Occlusion pressure will be assessed while the participant is in a supine position by inflating a pneumatic cuff placed on the thigh until the tibial artery pulse is no longer detectable, which will be confirmed using a handheld Doppler device. To ensure safe adaptation to the training protocol, the pressure applied during the first two training sessions will be set below the individually determined target pressure. The full target occlusion pressure will be implemented starting from the third training session. For example, if the target pressure is determined as 300 mmHg, exercises will be performed at 200 mmHg during the first session and 250 mmHg during the second session. Blood flow restriction training principles will be applied during exercise loading. Four different types of exercises will be set up in four sets.

Study groups in NCT07340385
Study groupRoleWhat they receive
Novice Training GroupThis group consists of healthy individuals who are new to strength training. Participants in this group will perform low-intensity resistance exercises with blood flow restriction applied to the proximal thigh using an inflatable cuff.
Receives: Other: Blood Flow Restriction Training
Experienced Athletes GroupThis group includes healthy experienced athletes from different sports disciplines and training load levels. Participants will perform the same low-intensity blood flow restriction exercise protocol applied to the proximal thigh using an inflatable cuff.
Receives: Other: Blood Flow Restriction Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Muscle Thickness

    Measured: Baseline and after 6 weeks of training

  2. Blood Biomarkers

    Oxidative Stress Markers Growth Factor Levels Muscle Damage Markers

    Measured: Blood samples will be collected at three time points: before and immediately after the third training session to assess acute responses, and at the end of the 6-week training period to assess long-term effects.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jan 2026
  2. Study start20 Jan 2026
  3. Primary completion20 Jan 2027 (estimated)
  4. Study completion20 Mar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07340385
Sponsor's protocol ID
2025/9
Status last verified
Jan 2026
First submitted
6 Jan 2026
Last updated
13 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Nielsen JL, Aagaard P, Prokhorova TA, Nygaard T, Bech RD, Suetta C, Frandsen U. Blood flow restricted training leads to myocellular macrophage infiltration and upregulation of heat shock proteins, but no apparent muscle damage. J Physiol. 2017 Jul 15;595(14):4857-4873. doi: 10.1113/JP273907. Epub 2017 Jun 23.

    PubMed 28481416
  • Centner C, Zdzieblik D, Dressler P, Fink B, Gollhofer A, Konig D. Acute effects of blood flow restriction on exercise-induced free radical production in young and healthy subjects. Free Radic Res. 2018 Apr;52(4):446-454. doi: 10.1080/10715762.2018.1440293. Epub 2018 Mar 15.

    PubMed 29448855
  • Franchi MV, Longo S, Mallinson J, Quinlan JI, Taylor T, Greenhaff PL, Narici MV. Muscle thickness correlates to muscle cross-sectional area in the assessment of strength training-induced hypertrophy. Scand J Med Sci Sports. 2018 Mar;28(3):846-853. doi: 10.1111/sms.12961. Epub 2017 Sep 21.

    PubMed 28805932

Questions about this trial

What is this clinical trial studying?

An observational study of Healthy Individuals and Trained Athletes, run by Afyonkarahisar Health Sciences University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 13 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Dilara KARA (+90 530 237 1991, dilaradonder@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Muscle Thickness (time frame: Baseline and after 6 weeks of training). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07340385, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2026; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in